1Comelis T, Broers NJ, Titulaer DC, et al. Effects of ultrapurehemodialysis and low molecular weight heparin on theendothelial surface layer[J].Blood Purif,2014,38(3-4):203-210.
2Lavainne F, Meffray E, Pepper RJ, et al. Heparin use duringdialysis sessions induces an increase in the antiangiogenic factorsoluble Fit 1[J].Nephrol Dial Transplant,2014,29(6): 1225-1231.
3Harenberg J, Hentschel VA, Du S, et al. Anticoagulation inpatients with impaired renal function and with haemodialysis.Anticoagulant effects, efficacy, safety, therapeutic options [J].Hamostaseologie,2015,35(1):77-83.
4Ezzatzadegan Jahromi S, Mahmoodi MS, Behroozi F, et al. Effectof switching unfractionated heparin to low-molecular-weightheparin on serum potassium in hemodialysis patients [J].Iran JKidney Dis,2014,8(6):475-480.
